Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Meta-Analysis
. 2023 Sep:134:160-167.
doi: 10.1016/j.ijid.2023.06.009. Epub 2023 Jun 15.

Prepandemic cross-reactive humoral immunity to SARS-CoV-2 in Africa: Systematic review and meta-analysis

John P A Ioannidis  1 , Despina G Contopoulos-Ioannidis  2
Affiliations
Meta-Analysis

Prepandemic cross-reactive humoral immunity to SARS-CoV-2 in Africa: Systematic review and meta-analysis

John P A Ioannidis et al. Int J Infect Dis. 2023 Sep.

Abstract

Objectives: To assess the evidence on the presence of antibodies cross-reactive with SARS-CoV-2 antigens in prepandemic samples from African populations.

Methods: We performed a systematic review and meta-analysis of studies evaluating prepandemic African samples using pre-set assay-specific thresholds for SARS-CoV-2 seropositivity.

Results: In total, 26 articles with 156 datasets were eligible, including 3437 positives among 29,923 measurements (11.5%) with large between-dataset heterogeneity. Positivity was similar for anti-nucleocapsid (14%) and anti-spike antibodies (11%), higher for anti-spike1 (23%), and lower for anti-receptor-binding domain antibodies (7%). Positivity was similar, on average, for immunoglobulin M and immunoglobulin G. Positivity was seen prominently in countries where malaria transmission occurs throughout and in datasets enriched in malaria cases (14%, 95% confidence interval, 12-15% vs 2%, 95% confidence interval 1-2% in other datasets). Substantial SARS-CoV-2 reactivity was seen in high malaria burden with or without high dengue burden (14% and 12%, respectively), and not without high malaria burden (2% and 0%, respectively). Lower SARS-CoV-2 cross-reactivity was seen in settings of high HIV seroprevalence. More sparse individual-level data showed associations of higher SARS-CoV-2 cross-reactivity with Plasmodium parasitemia and lower SARS-CoV-2 cross-reactivity with HIV seropositivity.

Conclusion: Prepandemic samples from Africa show high levels of anti-SARS-CoV-2 seropositivity. At the country level, cross-reactivity tracks especially with malaria prevalence.

Keywords: COVID-19; Cross-reactivity; Malaria; Prepandemic; SARS-CoV-2; Seroprevalence.

PubMed Disclaimer

Conflict of interest statement

Declarations of Competing Interest The authors have no competing interests to declare.

Figures

Figure 1
Figure 1
Flow diagram for searches and selected eligible studies.
See this image and copyright information in PMC

References

    1. Adams J, MacKenzie MJ, Amegah AK, Ezeh A, Gadanya MA, Omigbodun A, et al. The conundrum of low COVID-19 mortality burden in sub-Saharan Africa: myth or reality? Glob Health Sci Pract. 2021;9:433–443. doi: 10.9745/GHSP-D-21-00172. - DOI - PMC - PubMed
    1. Ioannidis JPA. Over- and under-estimation of COVID-19 deaths. Eur J Epidemiol. 2021;36:581–588. doi: 10.1007/s10654-021-00787-9. - DOI - PMC - PubMed
    1. Munn Z, Moola S, Riitano D, Lisy K. The development of a critical appraisal tool for use in systematic reviews addressing questions of prevalence. Int J Health Policy Manag. 2014;3:123–128. doi: 10.15171/ijhpm.2014.71. - DOI - PMC - PubMed
    1. Lau J, Ioannidis JP, Schmid CH. Quantitative synthesis in systematic reviews. Ann Intern Med. 1997;127:820–826. doi: 10.7326/0003-4819-127-9-199711010-00008. - DOI - PubMed
    1. Ioannidis JP. Interpretation of tests of heterogeneity and bias in meta-analysis. J Eval Clin Pract. 2008;14:951–957. doi: 10.1111/j.1365-2753.2008.00986.x. - DOI - PubMed